8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 2, 2010

Commission File No. 0-11178

UTAH MEDICAL PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

UTAH	87-0342734
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

7043 South 300 West

          Midvale, Utah  84047          

Address of principal executive offices

Registrant's telephone number:        (801) 566-1200

ITEM 8.01 OTHER EVENTS

On November 2, 2010, Utah Medical Products, Inc. announced that it will pay a special cash dividend.  A dividend of $.96 per share is payable on December 30, 2010 to shareholders of record at the close of business on December 15, 2010.  A copy of the press release is attached hereto as Exhibit 99.1

SIGNATURES

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	UTAH MEDICAL PRODUCTS, INC.
	REGISTRANT
Date:         11/2/2010	By:      /s/ Kevin L. Cornwell
	Kevin L. Cornwell
	CEO

EXHIBIT INDEX

Index
Number	Description
99.1	Press release issued November 2, 2010: Utah Medical Products, Inc. Announces Special Dividend

EX-99.1

EXHIBIT 99.1

Salt Lake City, Utah - Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a special cash dividend of ninety-six cents ($.96) per share of common stock payable on December 30, 2010 to shareholders of record at the close of business on December 15, 2010.  The one-time dividend represents about a two percent (2%) increase over the cumulative cash dividends of ninety-four cents ($.94) paid during the most recent four calendar quarters.

A key long term UTMD business objective has been to maximize returns for its shareholders. In recent quarters, the Company has been paying out over half of its profits after corporate income taxes to shareholders.

Chairman Kevin Cornwell states, “I believe shareholders can view this $3.5 million special dividend in the following ways:

1)  As almost half of UTMD’s shareholders are individuals who are affected by personal income taxes on dividends, the special dividend removes uncertainty regarding the government’s tax policy for next year. It represents what the board of directors estimates it probably would have declared as normal dividends for the next four calendar quarters, in effect, a prepayment of 2011 shareholder dividends.

2) The amount of the special dividend will reduce UTMD’s cash and investment balances to about where they were a little over a year ago, even though in 2010 UTMD has already made regular quarterly dividend payments, repurchased shares in the open market, invested in facility expansion in Utah, invested in new technology and made other capital expenditures, all totaling nearly $5 million. We do not expect that the special dividend will impair UTMD’s ability to continue similar investments or make an acquisition that will improve business activity, if one comes along that meets UTMD’s investment criteria.”

Investors are cautioned that this press release contains forward looking statements and that actual events may differ from those projected or expected.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures, assembles and markets a broad range of disposable and reusable specialty medical devices.